USANA Health Sciences, Inc.
corporate_fare Company Profile
USANA Health Sciences, Inc. (NYSE:USNA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for USNA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for USNA spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Q3 Sales Fall 4%, Guidance Cut as Core Customer Base Shrinks 8%
- USANA's Q2 10-Q confirms a $29.1M Hiya goodwill impairment and a $21.4M net loss
- USANA Swings to Q2 Loss on $29M Hiya Impairment, Slashes 2026 Guidance
- Q1 Earnings Decline 20% Amidst Core Customer Losses, Despite Growth in New Segments
- USANA Health Sciences Q1 Revenue Flat, Profit Drops; Reaffirms FY26 Guidance
Financial Snapshot
Short Interest & Short Volume
5.15 days to coverFINRA reported short interest of 879,205 shares in USNA as of the October 30, 2026 settlement, a 12.9% increase from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 57.2% of USNA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.